The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases

SummaryThe enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase catalyzes the conversion of HMG-CoA to mevalonate, a four-electron oxidoreduction that is the rate-limiting step in the synthesis of cholesterol and other isoprenoids. The enzyme is found in eukaryotes and prokaryotes; and phylogenetic analysis has revealed two classes of HMG-CoA reductase, the Class I enzymes of eukaryotes and some archaea and the Class II enzymes of eubacteria and certain other archaea. Three-dimensional structures of the catalytic domain of HMG-CoA reductases from humans and from the bacterium Pseudomonas mevalonii, in conjunction with site-directed mutagenesis studies, have revealed details of the mechanism of catalysis. The reaction catalyzed by human HMG-CoA reductase is a target for anti-hypercholesterolemic drugs (statins), which are intended to lower cholesterol levels in serum. Eukaryotic forms of the enzyme are anchored to the endoplasmic reticulum, whereas the prokaryotic enzymes are soluble. Probably because of its critical role in cellular cholesterol homeostasis, mammalian HMG-CoA reductase is extensively regulated at the transcriptional, translational, and post-translational levels.

[1]  J. Goldstein,et al.  Replacement of serine-871 of hamster 3-hydroxy-3-methylglutaryl-CoA reductase prevents phosphorylation by AMP-activated kinase and blocks inhibition of sterol synthesis induced by ATP depletion. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Joseph L Goldstein,et al.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.

[3]  J. Deisenhofer,et al.  Structural Mechanism for Statin Inhibition of HMG-CoA Reductase , 2001, Science.

[4]  David E. Cane,et al.  Isoprenoids including carotenoids and steroids , 1999 .

[5]  Lydia Tabernero,et al.  Crystal Structure of a Statin Bound to a Class II Hydroxymethylglutaryl-CoA Reductase* , 2003, Journal of Biological Chemistry.

[6]  A. Fürholz,et al.  Crosstalk between cytosolic and plastidial pathways of isoprenoid biosynthesis in Arabidopsis thaliana , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Deisenhofer,et al.  The structure of the catalytic portion of human HMG-CoA reductase. , 2000, Biochimica et biophysica acta.

[8]  J. Nordstrom,et al.  Regulation of HMG-CoA reductase. , 1976, Advances in lipid research.

[9]  V. Rodwell,et al.  Sequence comparisons reveal two classes of 3-hydroxy-3-methylglutaryl coenzyme A reductase. , 1999, Molecular genetics and metabolism.

[10]  V. Rodwell,et al.  2.02 – Biosynthesis of Mevalonic Acid from Acetyl-CoA , 1999 .

[11]  C. M. Lawrence,et al.  Crystal structure of Pseudomonas mevalonii HMG-CoA reductase at 3.0 angstrom resolution. , 1995, Science.

[12]  E. Istvan,et al.  Bacterial and mammalian HMG-CoA reductases: related enzymes with distinct architectures. , 2001, Current opinion in structural biology.

[13]  M. Brown,et al.  Partial deletion of membrane-bound domain of 3-hydroxy-3-methylglutaryl coenzyme A reductase eliminates sterol-enhanced degradation and prevents formation of crystalloid endoplasmic reticulum , 1987, The Journal of cell biology.

[14]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[15]  J. Goldstein,et al.  Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. , 2003, Molecular cell.

[16]  R. D. Simoni,et al.  The inhibition of degradation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase by sterol regulatory element binding protein cleavage-activating protein requires four phenylalanine residues in span 6 of HMG-CoA reductase transmembrane domain. , 2003, Archives of biochemistry and biophysics.

[17]  D. Hardie Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0982 Minireview: The AMP-Activated Protein Kinase Cascade: The Key Sensor of Cellular Energy Status , 2022 .

[18]  L. Tabernero,et al.  Substrate-induced closure of the flap domain in the ternary complex structures provides insights into the mechanism of catalysis by 3-hydroxy-3-methylglutaryl-CoA reductase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Joseph L Goldstein,et al.  Insig-dependent Ubiquitination and Degradation of Mammalian 3-Hydroxy-3-methylglutaryl-CoA Reductase Stimulated by Sterols and Geranylgeraniol* , 2003, Journal of Biological Chemistry.

[20]  S. Venkatesan,et al.  1 – Membrane-Mediated Control of Reductase Activity , 1985 .

[21]  D. Hardie,et al.  Bacterial expression of the catalytic domain of 3-hydroxy-3-methylglutaryl-CoA reductase (isoform HMGR1) from Arabidopsis thaliana, and its inactivation by phosphorylation at Ser577 by Brassica oleracea 3-hydroxy-3-methylglutaryl-CoA reductase kinase. , 1995, European journal of biochemistry.

[22]  Lydia Tabernero,et al.  Coenzyme a Reductases Class Ii 3-hydroxy-3-methylglutaryl , 2022 .

[23]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[24]  J. Deisenhofer,et al.  Crystal structure of the catalytic portion of human HMG‐CoA reductase: insights into regulation of activity and catalysis , 2000, The EMBO journal.